All Stories

  1. Hypertension in Pregnancy: Unanswered Questions

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Konstantinos Stavropoulos, Dr Vasilios Papademetriou

  2. The Impact of Various Blood Pressure Measurements on Cardiovascular Outcomes

    Article • Current Vascular Pharmacology, December 2020, Bentham Science Publishers

    Konstantinos Stavropoulos

  3. Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis

    Article • Current Diabetes Reviews, April 2020, Bentham Science Publishers

    Prof Vasilios Kotsis, Konstantinos Stavropoulos, Konstantinos Imprialos

  4. Dysmetabolic Iron Overload in Metabolic Syndrome

    Article • Current Pharmaceutical Design, April 2020, Bentham Science Publishers

    Konstantinos Imprialos, Professor Vasilios Gabriel Athyros, Konstantinos Stavropoulos

  5. Primary Aldosteronism: Novel Insights

    Article • Current Hypertension Reviews, February 2020, Bentham Science Publishers

    Konstantinos Stavropoulos, Konstantinos Imprialos

  6. Hypertension in Metabolic Syndrome: Novel Insights

    Article • Current Hypertension Reviews, February 2020, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  7. Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus

    Article • Vascular Health and Risk Management, August 2019, Taylor & Francis

    Konstantinos Stavropoulos, Dr Vasilios Papademetriou

  8. The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction

    Article • Current Pharmaceutical Design, April 2019, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos

  9. Mineralocorticoid Receptor Antagonists in Primary Aldosteronism

    Article • Current Pharmaceutical Design, April 2019, Bentham Science Publishers

    Konstantinos Stavropoulos, Konstantinos Koutsampasopoulos

  10. Mineralocorticoid Receptor Antagonists in Cardiovascular Medicine: Looking for the Forest Among the Trees

    Article • Current Pharmaceutical Design, April 2019, Bentham Science Publishers

    Konstantinos Stavropoulos

  11. Understanding the cardiovascular risk with non-insulin antidiabetic drugs

    Article • Expert Opinion on Drug Safety, March 2019, Taylor & Francis

    Konstantinos Imprialos, Professor Vasilios Gabriel Athyros, Konstantinos Stavropoulos

  12. The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease

    Article • Current Pharmaceutical Design, February 2019, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  13. SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature

    Article • Current Clinical Pharmacology, January 2019, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  14. Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints

    Article • Current Pharmaceutical Design, September 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  15. Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos

  16. Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Kyriakos Dimitriadis

  17. Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Kyriakos Dimitriadis

  18. Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Stavropoulos

  19. Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome

    Article • Gynecological Endocrinology, June 2018, Taylor & Francis

    Konstantinos Stavropoulos, Konstantinos Imprialos

  20. Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

    Article • Journal of Clinical Hypertension, May 2018, Wiley

    Konstantinos Stavropoulos

  21. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis

    Article • Current Vascular Pharmacology, March 2018, Bentham Science Publishers

    Konstantinos Stavropoulos, Peter Kokkinos

  22. Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease

    Article • Current Vascular Pharmacology, March 2018, Bentham Science Publishers

    Konstantinos Stavropoulos

  23. What is the role of statins in the elderly population?

    Article • Expert Review of Clinical Pharmacology, February 2018, Taylor & Francis

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  24. Renal resistive index for renovascular hypertension: In the quest of the Holy Grail

    Article • Journal of Clinical Hypertension, February 2018, Wiley

    Konstantinos Imprialos, Konstantinos Stavropoulos

  25. The potential role of statins in treating liver disease

    Article • Expert Review of Gastroenterology & Hepatology, February 2018, Taylor & Francis

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  26. Carotid intima-media thickness as a target-organ damage and treatment-target: Need for a major revision?

    Article • Journal of Clinical Hypertension, February 2018, Wiley

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  27. Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy

    Article • Current Vascular Pharmacology, January 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos

  28. Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension

    Article • Journal of Clinical Hypertension, December 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  29. Antihypertensive drug treatment: the real-life challenge

    Article • Journal of Clinical Hypertension, December 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  30. Abnormal blood pressure dipping in diabetic kidney disease: A black-race nightmare?

    Article • Journal of Clinical Hypertension, September 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  31. Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

    Article • Journal of Clinical Hypertension, July 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos